Gene therapies are emerging as a new force for hope across the medical spectrum and perhaps offer the most immediately impactful solution to multiple ophthalmic diseases.
Today, gene therapies are administered to target tissues in a random manor, however DARC offers the opportunity to identify active or non-active disease sites within the retina. This ability will enable you to correctly administer gene therapies to the target tissue.
HOW CAN DARC HELP YOU?
ASSISTING TARGETED DELIVERY
DARC can be used in gene therapy by pin-pointing anatomical disease activity, your gene therapy can then be targeted to the appropriate area.
De-risk your gene & cell therapies with DARC.